Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer-Reference-Cited by-同舟云学术

Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer

Published:2002-07 Issue:3 Volume:87 Page:334-338
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Anderson T J,Dixon J M,Stuart M,Sahmoud T,Miller W R

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6600435.pdf

Reference29 articles.

1. Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11: 155–168

2. Anderson ED, Forrest AP, Levack PA, Chetty U, Hawkins RA (1989) Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer. Br J Cancer 60: 223–226

3. Bajetta E, Zilembo N, Bichisao E (1999) Aromatase inhibitors in the treatment of postmenopausal breast cancer. Drugs Aging 15: 271–283

4. Bajetta E, Zilembo N, Bichisao E, Martinetti A, Buzzoni R, Pozzi P, Bidoli P, Ferrari L, Celio L (2000) Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors. Ann Oncol 11: 1017–1022

5. Bonneterre J, Buzdar A, Nabholtz JM, Robertson JFR, Thurlimann B, von Euler M, Sahmoud T, Webster A, Steinberg M (2001) Anastrozole (Arimidex) is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast cancer: results of two randomized trials designed for combined analysis. Cancer 92: 2248–2258

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological Changes Following Neoadjuvant Endocrine Therapy (NAET): A Multicentre Study of 391 Breast Cancers;International Journal of Molecular Sciences;2024-07-05

2. Pathology of neoadjuvant therapy and immunotherapy testing for breast cancer;Histopathology;2022-12-08

3. Molecular Biomarker Expression in Window of Opportunity Studies for Oestrogen Receptor Positive Breast Cancer—A Systematic Review of the Literature;Cancers;2022-10-14

4. Receptor Status after Neoadjuvant Therapy of Breast Cancer: Significance and Implications;Pathobiology;2022

5. The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer;Annals of Surgical Oncology;2020-06-26